Fig. 2From: Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective studyKaplan-Meier curves of relapse-free survival (a) among patients treated with carboplatin plus gemcitabine. Relapse-free survival in patients with adenocarcinoma (b) and squamous cell carcinoma (c). And overall survival (d) among themBack to article page